Effect of SMAD4 gene polymorphism on breast cancer risk in Bangladeshi women

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  R. Kordek,et al.  Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research , 2021, Pharmacogenomics and personalized medicine.

[3]  M. Baudis,et al.  Enabling population assignment from cancer genomes with SNP2pop , 2020, Scientific Reports.

[4]  K. Czene,et al.  The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study , 2020, Acta radiologica.

[5]  S. Paik,et al.  Clinicopathological Significance of SMAD4 Expression in Breast Cancer , 2019, Journal of Breast Disease.

[6]  Shanmugam Veeramani,et al.  Machine Learning Classification Techniques for Breast Cancer Diagnosis , 2019, IOP Conference Series: Materials Science and Engineering.

[7]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[8]  J. Pelletier,et al.  Exploring the Impact of Single-Nucleotide Polymorphisms on Translation , 2018, Front. Genet..

[9]  Mohammad Safiqul Islam,et al.  Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population. , 2017, Cancer epidemiology.

[10]  Sharmin Afroz,et al.  A Study Survey on Risk Factors Associated with Breast Cancer in Bangladeshi Population , 2017 .

[11]  K. Shaw,et al.  Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer , 2017, PloS one.

[12]  A. Hata,et al.  TGF-β Signaling from Receptors to Smads. , 2016, Cold Spring Harbor perspectives in biology.

[13]  K. Fitch,et al.  Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. , 2016, American health & drug benefits.

[14]  Chunyan Yu,et al.  SMAD4 expression in breast ductal carcinoma correlates with prognosis. , 2015, Oncology letters.

[15]  Nandakumar Balasubramanian,et al.  Introduction to Cancer Biology , 2015, The Yale Journal of Biology and Medicine.

[16]  Mohammad Safiqul Islam,et al.  Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi population , 2015, Clinical and experimental pharmacology & physiology.

[17]  B. Frey,et al.  The human splicing code reveals new insights into the genetic determinants of disease , 2015, Science.

[18]  B. Ring,et al.  Ethnic Background and Genetic Variation in the Evaluation of Cancer Risk: A Systematic Review , 2014, PloS one.

[19]  G. Chenevix-Trench,et al.  Growing recognition of the role for rare missense substitutions in breast cancer susceptibility. , 2014, Biomarkers in medicine.

[20]  J. Massagué.  TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.

[21]  B. Peshkin,et al.  Interest in Genetic Testing for Modest Changes in Breast Cancer Risk: Implications for SNP Testing , 2011, Public Health Genomics.

[22]  M. Tan,et al.  Genetic variations in the SMAD4 gene and gastric cancer susceptibility. , 2010, World journal of gastroenterology.

[23]  Martha L. Slattery,et al.  Genetic Variation in the TGF-β Signaling Pathway and Colon and Rectal Cancer Risk , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  A. Derossis,et al.  Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.

[25]  M. Nagarkatti,et al.  Unique SNP in CD44 intron 1 and its role in breast cancer development. , 2010, Anticancer research.

[26]  Rahul Dave,et al.  VARIOUS TYPES AND MANAGEMENT OF BREAST CANCER: AN OVERVIEW , 2010, Journal of advanced pharmaceutical technology & research.

[27]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[28]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[29]  R. Scott,et al.  Missense Mutations in Cancer Predisposing Genes: Can We Make Sense of Them? , 2005, Hereditary cancer in clinical practice.

[30]  Yi Sun,et al.  Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-α-positive Breast Cancer Cells* , 2005, Journal of Biological Chemistry.

[31]  S. Chanock,et al.  SNPs in cancer research and treatment , 2004, British Journal of Cancer.

[32]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[33]  W. F. Bodmer,et al.  SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. You,et al.  Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes. , 1997, Carcinogenesis.

[35]  H. Inoko,et al.  Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. , 1991, Tissue antigens.

[36]  S. Mohammed,et al.  Breast cancer metastasis and the lymphatic system. , 2015, Oncology letters.

[37]  B. Pasche,et al.  SMAD4 is a potential prognostic marker in human breast carcinomas , 2013, Tumor Biology.

[38]  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[40]  J. Smart,et al.  Analysis of cytochrome P450 polymorphisms. , 1998, Methods in molecular biology.